The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes
OPHELIA
OPHthalmic artEry DoppLer Evaluation After 37 Weeks of Gestation and Intrapartum Fetal Adverse Outcomes (the OPHELIA Study)
1 other identifier
interventional
1,477
0 countries
N/A
Brief Summary
The ophthalmic artery Doppler has been recently proposed as a potential "soft marker" for placental insufficiency in retrospective and observational studies, with similar clinical significance with respect to Uterine Artery (UA) Doppler evaluation and it is currently being investigated as an adjunctive clinical instrument to predict pre-eclampsia (PE) occurrence. Placental insufficiency strictly correlates with intrapartum fetal adverse outcomes and a concomitant induction of labor, alone, may further increase the hypoxic stress on the fetus during labor. This can be reflected by cardiotocographic alterations during labor, ultimately leading to emergency cesarean deliveries or instrumental vaginal deliveries. Despite great advancements in understanding various maternal-fetal pathologies, the investigators are still not able to properly detect fetuses that are at higher risk for intrapartum compromise among those receiving an induction of labor. Therefore, the aim of this prospective study is to investigate any potential association between altered ophthalmic artery Doppler PSV ratio measured before labor induction in at-term, pregnant patients with intra-partum fetal compromise. Furthermore, the investigators aim to also measure an additional parameter that is the optic nerve sheath diameter (ONSD) - an indirect measure of intracranial pressure - before and after the second stage of labour, with the aim of studying its physiology during and after delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2026
CompletedStudy Start
First participant enrolled
September 24, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
September 29, 2026
September 1, 2026
7 months
September 16, 2026
September 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of in-labor cesarean delivery due to fetal hypoxic stress, assessed in relation to maternal ophthalmic artery Doppler indices measured before induction of labor.
Occurrence of cesarean delivery during labor due to fetal hypoxic stress, evaluated in relation to maternal ophthalmic artery Doppler indices measured before induction of labor.
From start of labor induction until delivery, up to 72 hours.
Secondary Outcomes (6)
instrumental vaginal delivery for fetal hypoxic stress
From start of labor induction until delivery, up to 72 hours.
Cesarean delivery for any indication
From start of labor induction until delivery, up to 72 hours.
Cesarean delivery for clinical or subclinical chorioamnionitis
From start of labor induction until delivery, up to 72 hours.
Umbilical arterial pH <7.0
At delivery
5-minute Apgar score <7
5 minutes after birth
- +1 more secondary outcomes
Other Outcomes (1)
Change in Optic Nerve Sheath Diameter (ONSD)
Before labor induction and up to 30 minutes after delivery
Study Arms (1)
Ophthalmic Artery Doppler Assessment
EXPERIMENTALPregnant patients after 37 weeks of gestation undergoing induction of labor. Before labor induction, participants will undergo maternal ophthalmic artery Doppler assessment and measurement of optic nerve sheath diameter (ONSD). ONSD will be measured again after delivery. Maternal, intrapartum, and neonatal outcomes will be collected.
Interventions
Right before labour induction, once the patient is already admitted into the inpatient ward - as an elective admission for scheduled labour induction - we will perform an ultrasound by gently applying the probe onto the eyelid of the patient, using sterile gel. We will then measure both the Doppler velocity of the Ophthalmic Artery as well as the Optic Nerve Sheath Diameter (ONSD). The ONSD will then be measured again right after delivery following the exact same procedure.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Pregnant patients after 37 weeks of gestation undergoing induction of labor
- Ability to provide written informed consent
You may not qualify if:
- Age \<18 years
- Known fetal malformations
- Known fetal genetic syndromes
- Multiple pregnancy
- Known maculopathies
- Inability or unwillingness to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (14)
Singh SK, Bhatia K. Ultrasonographic Optic Nerve Sheath Diameter as a Surrogate Measure of Raised Intracranial Pressure in Severe Pregnancy-induced Hypertension Patients. Anesth Essays Res. 2018 Jan-Mar;12(1):42-46. doi: 10.4103/aer.AER_218_17.
PMID: 29628552BACKGROUNDBerty Gutierrez H, Carrera Gonzalez E. Usefulness of optic nerve sheath diameter measurement in hypertensive patients during pregnancy and the puerperium. J Matern Fetal Neonatal Med. 2023 Dec;36(1):2187253. doi: 10.1080/14767058.2023.2187253.
PMID: 36889743BACKGROUNDRossi AC, Prefumo F. Antepartum and intrapartum risk factors for neonatal hypoxic-ischemic encephalopathy: a systematic review with meta-analysis. Curr Opin Obstet Gynecol. 2019 Dec;31(6):410-417. doi: 10.1097/GCO.0000000000000581.
PMID: 31567446BACKGROUNDGhi T, Fieni S, Ramirez Zegarra R, Pereira S, Dall'Asta A, Chandraharan E. Relative uteroplacental insufficiency of labor. Acta Obstet Gynecol Scand. 2024 Oct;103(10):1910-1918. doi: 10.1111/aogs.14937. Epub 2024 Aug 6.
PMID: 39107951BACKGROUNDdi Pasquo E, Giannubilo SR, Valentini B, Salvi S, Rullo R, Fruci S, Filippi E, Ornaghi S, Zullino S, Rossi F, Farsetti D, Di Martino DD, Vasapollo B, Locatelli A, De Santis M, Ciavattini A, Lanzone A, Mecacci F, Ferrazzi E, Valensise H, Ghi T. The "Preeclampsia and Hypertension Target Treatment" study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings. Am J Obstet Gynecol MFM. 2024 May;6(5):101368. doi: 10.1016/j.ajogmf.2024.101368. Epub 2024 Apr 3.
PMID: 38574856BACKGROUNDAli S, Mukasa DC, Lukakamwa D, Nakayenga A, Namagero P, Biira J, Byamugisha J, Papageorghiou AT. Relationship of maternal ophthalmic artery Doppler with uterine artery Doppler, hemodynamic indices and gestational age: prospective MATERA study. Ultrasound Obstet Gynecol. 2025 Feb;65(2):163-172. doi: 10.1002/uog.29162. Epub 2025 Jan 20.
PMID: 39831889BACKGROUNDGurgel Alves JA, Maia e Holanda Moura SB, Araujo Junior E, Tonni G, Martins WP, Da Silva Costa F. Predicting small for gestational age in the first trimester of pregnancy using maternal ophthalmic artery Doppler indices. J Matern Fetal Neonatal Med. 2016;29(7):1190-4. doi: 10.3109/14767058.2015.1040755. Epub 2015 Jun 1.
PMID: 26030678BACKGROUNDArechvo A, Wright A, Nobile Recalde A, Liandro R, Charakida M, Nicolaides KH. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses. Ultrasound Obstet Gynecol. 2024 Mar;63(3):358-364. doi: 10.1002/uog.27521. Epub 2024 Feb 10.
PMID: 37902727BACKGROUNDCao L, He B, Zhou Y, Chen T, Gao Y, Yao B. Utility of uterine artery Doppler ultrasound imaging in predicting preeclampsia during pregnancy: a meta-analysis. Med Ultrason. 2024 Jun 21;26(2):197-204. doi: 10.11152/mu-4355. Epub 2024 Apr 15.
PMID: 38805623BACKGROUNDAbdel Azim S, Sarno M, Wright A, Vieira N, Charakida M, Nicolaides KH. Ophthalmic artery Doppler at 35-37 weeks' gestation in pregnancies with small or growth-restricted fetuses. Ultrasound Obstet Gynecol. 2022 Apr;59(4):483-489. doi: 10.1002/uog.24854. Epub 2022 Mar 4.
PMID: 35000242BACKGROUNDNicolaides KH, Sarno M, Wright A. Ophthalmic artery Doppler in the prediction of preeclampsia. Am J Obstet Gynecol. 2022 Feb;226(2S):S1098-S1101. doi: 10.1016/j.ajog.2020.11.039. Epub 2021 Apr 24.
PMID: 34292158BACKGROUNDKalafat E, Laoreti A, Khalil A, Da Silva Costa F, Thilaganathan B. Ophthalmic artery Doppler for prediction of pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018 Jun;51(6):731-737. doi: 10.1002/uog.19002. Epub 2018 May 3.
PMID: 29330892BACKGROUNDSapantzoglou I, Wright A, Arozena MG, Campos RV, Charakida M, Nicolaides KH. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation. Ultrasound Obstet Gynecol. 2021 Jan;57(1):75-83. doi: 10.1002/uog.23528. Epub 2020 Dec 4.
PMID: 33142353BACKGROUNDSarno M, Wright A, Vieira N, Sapantzoglou I, Charakida M, Nicolaides KH. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol. 2021 Apr;57(4):600-606. doi: 10.1002/uog.23517. Epub 2021 Mar 15.
PMID: 33073902BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tullio Ghi
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Tullio Ghi, MD PhD
Study Record Dates
First Submitted
September 16, 2026
First Posted
September 29, 2026
Study Start
September 24, 2026
Primary Completion (Estimated)
April 15, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
September 29, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data (IPD) available.